2.45
7.93%
0.18
Dopo l'orario di chiusura:
2.45
Rapt Therapeutics Inc Azioni (RAPT) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.10%
32.52
|
33.22 | 33.92 | 28.36 | 31.56 |
Depreciation and Amortization |
2.79%
0.314
|
0.323 | 0.30 | 0.30 | 0.299 |
Operating Income/Loss |
2.10%
-32.52
|
-33.22 | -33.92 | -28.36 | -31.56 |
Nonoperating Income/Loss |
14.69%
1.997
|
2.341 | 2.548 | 3.084 | 2.291 |
Income/Loss From Continuing Operations Before Tax |
1.15%
-30.52
|
-30.88 | -31.37 | -25.28 | -29.27 |
Income/Loss From Continuing Operations After Tax |
1.15%
-30.52
|
-30.88 | -31.37 | -25.28 | -29.27 |
Net Income/Loss
|
1.15%
-30.52
|
-30.88 | -31.37 | -25.28 | -29.27 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
250.91K%
38.63
|
0.0154 | 38.36 | 38.33 | 38.28 |
Diluted Average Shares |
250.91K%
38.63
|
0.0154 | 38.36 | 38.33 | 38.28 |
Basic Earnings Per Share |
2.47%
-0.79
|
-0.81 | -0.82 | -0.66 | -0.76 |
Diluted Earnings Per Share |
2.47%
-0.79
|
-0.81 | -0.82 | -0.66 | -0.76 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):